{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:34:45Z","timestamp":1778916885473,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00415-021-10534-5","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T09:07:46Z","timestamp":1617268066000},"page":"742-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A systematic review and meta-analyses on the prevalence of pregnancy outcomes in migraine treated patients: a contribution from the IMI2 ConcePTION project"],"prefix":"10.1007","volume":"269","author":[{"given":"Daniel C.","family":"Dudman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Tauqeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moninder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Ritchey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7504-3441","authenticated-orcid":false,"given":"Sandra","family":"Lopez-Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"10534_CR1","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38(1):1\u2013211","DOI":"10.1177\/0333102417738202"},{"issue":"Suppl 1","key":"10534_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/head.13300","volume":"58","author":"DW Dodick","year":"2018","unstructured":"Dodick DW (2018) A phase-by-phase review of migraine pathophysiology. Headache 58(Suppl 1):4\u201316","journal-title":"Headache"},{"issue":"10127","key":"10534_CR3","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0140-6736(18)30478-1","volume":"391","author":"DW Dodick","year":"2018","unstructured":"Dodick DW (2018) Migraine. Lancet 391(10127):1315\u20131330","journal-title":"Lancet"},{"issue":"5","key":"10534_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68(5):343\u2013349","journal-title":"Neurology"},{"issue":"1","key":"10534_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/head.13665","volume":"60","author":"R Burch","year":"2020","unstructured":"Burch R (2020) Epidemiology and treatment of menstrual migraine and migraine during pregnancy and lactation: a narrative review. Headache 60(1):200\u2013216","journal-title":"Headache"},{"key":"10534_CR6","unstructured":"World Health Organization [WHO] (2011) Atlas of headache disorders and resources in the world 2011. A collaborative project of World Health Organization and Lifting the Burden. [cited 2020 November 19]; Available from http:\/\/apps.who.int\/iris\/handle\/10665\/44571"},{"issue":"4","key":"10534_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrneurol.2015.29","volume":"11","author":"S Amundsen","year":"2015","unstructured":"Amundsen S et al (2015) Pharmacological treatment of migraine during pregnancy and breastfeeding. Nat Rev Neurol 11(4):209\u2013219","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10534_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/head.12540","volume":"55","author":"D Tepper","year":"2015","unstructured":"Tepper D (2015) Pregnancy and lactation\u2013migraine management. Headache 55(4):607\u2013608","journal-title":"Headache"},{"key":"10534_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejogrb.2019.07.021","volume":"240","author":"V Tanos","year":"2019","unstructured":"Tanos V et al (2019) Review of migraine incidence and management in obstetrics and gynaecology. Eur J Obstet Gynecol Reprod Biol 240:248\u2013255","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10534_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","volume":"17","author":"T Tomson","year":"2018","unstructured":"Tomson T et al (2018) Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 17(6):530\u2013538","journal-title":"Lancet Neurol"},{"issue":"1","key":"10534_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/head.14041","volume":"61","author":"IJ Saldanha","year":"2021","unstructured":"Saldanha IJ et al (2021) Management of primary headaches during pregnancy, postpartum, and breastfeeding: a systematic review. Headache 61(1):11\u201343","journal-title":"Headache"},{"issue":"6","key":"10534_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1055\/s-0038-1673681","volume":"38","author":"E Sader","year":"2018","unstructured":"Sader E, Rayhill M (2018) Headache in pregnancy, the puerperium, and menopause. Semin Neurol 38(6):627\u2013633","journal-title":"Semin Neurol"},{"issue":"3","key":"10534_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3163\/1536-5050.104.3.014","volume":"104","author":"WM Bramer","year":"2016","unstructured":"Bramer WM et al (2016) De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc 104(3):240\u2013243","journal-title":"J Med Libr Assoc"},{"issue":"1","key":"10534_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M et al (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev 5(1):210","journal-title":"Syst Rev"},{"key":"10534_CR15","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer L et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647","journal-title":"BMJ"},{"issue":"Pt A","key":"10534_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cct.2015.05.009","volume":"45","author":"SA Doi","year":"2015","unstructured":"Doi SA et al (2015) Advances in the meta-analysis of heterogeneous clinical trials I: the inverse variance heterogeneity model. Contemp Clin Trials 45(Pt A):130\u2013138","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"10534_CR17","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","volume":"67","author":"JJ Barendregt","year":"2013","unstructured":"Barendregt JJ et al (2013) Meta-analysis of prevalence. J Epidemiol Community Health 67(11):974\u2013978","journal-title":"J Epidemiol Community Health"},{"key":"10534_CR18","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) (2020) Cochrane handbook for systematic reviews of interventions version 6.1 (updated September 2020). Cochrane","DOI":"10.1002\/9781119536604"},{"issue":"1\u20132","key":"10534_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s004040050252","volume":"263","author":"S O'Quinn","year":"1999","unstructured":"O\u2019Quinn S et al (1999) Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Arch Gynecol Obstet 263(1\u20132):7\u201312","journal-title":"Arch Gynecol Obstet"},{"issue":"8","key":"10534_CR20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2165\/11590370-000000000-00000","volume":"34","author":"B Kallen","year":"2011","unstructured":"Kallen B, Nilsson E, Olausson PO (2011) Delivery outcome after maternal use of drugs for migraine: a register study in Sweden. Drug Saf 34(8):691\u2013703","journal-title":"Drug Saf"},{"issue":"9","key":"10534_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10654-013-9831-x","volume":"28","author":"K Nezvalova-Henriksen","year":"2013","unstructured":"Nezvalova-Henriksen K, Spigset O, Nordeng H (2013) Triptan safety during pregnancy: a Norwegian population registry study. Eur J Epidemiol 28(9):759\u2013769","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10534_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1212\/WNL.51.2.581","volume":"51","author":"S Shuhaiber","year":"1998","unstructured":"Shuhaiber S et al (1998) Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 51(2):581\u2013583","journal-title":"Neurology"},{"issue":"6","key":"10534_CR23","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1177\/0333102417724152","volume":"38","author":"K Spielmann","year":"2018","unstructured":"Spielmann K et al (2018) Pregnancy outcome after anti-migraine triptan use: a prospective observational cohort study. Cephalalgia 38(6):1081\u20131092","journal-title":"Cephalalgia"},{"issue":"12","key":"10534_CR24","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/j.1468-2982.2009.01869.x","volume":"29","author":"K Nezvalova-Henriksen","year":"2009","unstructured":"Nezvalova-Henriksen K, Spigset O, Nordeng H (2009) Maternal characteristics and migraine pharmacotherapy during pregnancy: cross-sectional analysis of data from a large cohort study. Cephalalgia 29(12):1267\u20131276","journal-title":"Cephalalgia"},{"issue":"4","key":"10534_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/head.12500","volume":"55","author":"A Marchenko","year":"2015","unstructured":"Marchenko A et al (2015) Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis. Headache 55(4):490\u2013501","journal-title":"Headache"},{"issue":"12","key":"10534_CR26","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/OGX.0000000000000738","volume":"74","author":"AM Aukes","year":"2019","unstructured":"Aukes AM et al (2019) Associations between migraine and adverse pregnancy outcomes: systematic review and meta-analysis. Obstet Gynecol Surv 74(12):738\u2013748","journal-title":"Obstet Gynecol Surv"},{"issue":"4","key":"10534_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1526-4610.2010.01619.x","volume":"50","author":"K Nezvalova-Henriksen","year":"2010","unstructured":"Nezvalova-Henriksen K, Spigset O, Nordeng H (2010) Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache 50(4):563\u2013575","journal-title":"Headache"},{"issue":"8","key":"10534_CR28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1046\/j.1468-2982.2000.00112.x","volume":"20","author":"F Granella","year":"2000","unstructured":"Granella F et al (2000) Migraine with aura and reproductive life events: a case control study. Cephalalgia 20(8):701\u2013707","journal-title":"Cephalalgia"},{"key":"10534_CR29","unstructured":"Comission E (2020) European network of population based registries for the epidemiological surveillance of congenital anomalies. 2020 [cited 2020 August]. Available from https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat_en"},{"key":"10534_CR30","unstructured":"CDC (2019) Metropolitan atlanta congenital defects program (MACDP). [cited 2020 August]; Available from: https:\/\/www.cdc.gov\/ncbddd\/birthdefects\/macdp.html"},{"issue":"1","key":"10534_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1046\/j.1526-4610.2000.00003.x","volume":"40","author":"C Olesen","year":"2000","unstructured":"Olesen C et al (2000) Pregnancy outcome following prescription for sumatriptan. Headache 40(1):20\u201324","journal-title":"Headache"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10534-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10534-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10534-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T15:13:45Z","timestamp":1642778025000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10534-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10534"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10534-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DCD and SLL are employees of Novartis. MK is a former employee of Cognizant Technology Solutions on behalf of Novartis and a current employee of Barrington James Ltd on behalf of UCB. HL is a former employee of Eli Lilly and current employee of Gilead Science.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This article does not contain any studies with human particpiants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}